phase 2
ii 2
intergroup 1
trial 1
alisertib 2
relapsed 2
refractory 2
peripheral 1
tcell 2
lymphoma 1
transformed 1
mycosis 1
fungoides 1
swog 1
study 1
selective 1
aurora 1
kinase 1
inhibitor 1
aggressive 1
b 1
nonhodgkin 1
lymphomas 1
